ConductScience.org, home

Paper37065

Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

McDevitt DG. Drugs, 1979. Cited by 67 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use. Papers, record 37065. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37065

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.
PubMed
Journal
Drugs
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
4.53
iCite
Revised in PubMed
2026-10-11
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McDevitt DGD G

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic alpha-AntagonistsMajor topic
Adrenergic beta-AntagonistsMajor topic
Animals
Heart
Humans
Labetalol
Membranes

Source PubMed

References111

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,030,676Studies of the reputed augmentation of the cardiovascular effects of catecholamines in patients with spontaneous hyperthyroidism.J Pharmacol Exp Ther1972https://conductscience.org/library/papers/5030676PubMed
24,997,528Assessment of propranolol in angina pectoris. Clinical dose response curve and effect on electrocardiogram at rest and on exercise.Br Heart J1971https://conductscience.org/library/papers/4997528PubMed
3579,057A case of fatal propranolol intoxication.Acta Pharmacol Toxicol (Copenh)1977https://conductscience.org/library/papers/579057PubMed
41,233,216Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/1233216PubMed
5767,299Double blind study of propranolol for migraine prophylaxis.Headache1976https://conductscience.org/library/papers/767299PubMed
66,060,269Differentiation of receptors responsive to isoproterenol.Life Sci1967https://conductscience.org/library/papers/6060269PubMed
7861,130Evaluation of once daily sotalol administration in man.Br J Clin Pharmacol1977https://conductscience.org/library/papers/861130PubMed
810,954Closing remarks: current status of labetalol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10954PubMed
94,901,143Clinical response to long-term propranolol therapy in hyperthyroidism.S Afr Med J1969https://conductscience.org/library/papers/4901143PubMed
104,595,181Response to propranolol and diazepam in somatic and psychic anxiety.Br Med J1974https://conductscience.org/library/papers/4595181PubMed
111,115,130Treatment of thyrotoxicosis during pregnancy with propranolol.Am J Obstet Gynecol1975https://conductscience.org/library/papers/1115130PubMed
124,876,981Guanethidine-resistant hypertension.Circulation1968https://conductscience.org/library/papers/4876981PubMed
134,153,342Effects of thyroid state on adrenoceptor properties.Nature1974https://conductscience.org/library/papers/4153342PubMed
1410,948A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10948PubMed
1525,757Labetalol: a review of its pharmacology and therapeutic use in hypertension.Drugs1978https://conductscience.org/library/papers/25757PubMed
164,115,260Beneficial effect of beta-adrenergic blockade on "exam. nerves".Lancet1972https://conductscience.org/library/papers/4115260PubMed
174,139,587Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results.Lancet1974https://conductscience.org/library/papers/4139587PubMed
18788,758The effect on blood pressure of beta-adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.Br J Clin Pharmacol1976https://conductscience.org/library/papers/788758PubMed
1920,123The assessment of beta-adrenoceptor blocking drugs in man.Br J Clin Pharmacol1977https://conductscience.org/library/papers/20123PubMed
204,396,218Treatment of atrial arrhythmias with alprenolol.JAMA1970https://conductscience.org/library/papers/4396218PubMed

See all 111 references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
21,293,573Current status of Beta blocker therapy.Can Fam Physician1980https://conductscience.org/library/papers/21293573PubMed
7,617,516Soft drugs. XX. Design, synthesis, and evaluation of ultra-short acting beta-blockers.Pharm Res1995https://conductscience.org/library/papers/7617516PubMed
7,049,658Fixed combination drug therapy.Drugs1982https://conductscience.org/library/papers/7049658PubMed
6,733,006The effect of single doses of penbutolol and propranolol L.A. on psychomotor performance.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6733006PubMed
6,691,887Central effects of single oral doses of propranolol in man.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6691887PubMed
6,151,506Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6151506PubMed
6,133,735Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?Drugs1983https://conductscience.org/library/papers/6133735PubMed
6,122,340Improved deep controlled hypotension in aneurysmal surgery.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/6122340PubMed
3,933,040The effect of peripheral noradrenaline depletion on responding on a schedule of differential reinforcement of low rates of response (DRL).Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3933040PubMed
3,931,150Comparison between the effects of propranolol and chlordiazepoxide on timing behaviour in the rat.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3931150PubMed
3,885,985Comparative clinical efficacy of bepridil, propranolol and placebo in patients with chronic stable angina.Br J Clin Pharmacol1985https://conductscience.org/library/papers/3885985PubMed
3,402,525Pharmacokinetic-pharmacodynamic modelling of oxprenolol in man using continuous non-invasive blood pressure monitoring.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3402525PubMed
2,886,244Clinical pharmacokinetics of beta-adrenoceptor antagonists. An update.Clin Pharmacokinet1987https://conductscience.org/library/papers/2886244PubMed
2,875,397
Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
Naunyn Schmiedebergs Arch Pharmacol1986https://conductscience.org/library/papers/2875397PubMed
2,869,543Effects of propranolol on conditioned suppression, discriminated punishment and discriminated non-reward in the rat.Psychopharmacology (Berl)1986https://conductscience.org/library/papers/2869543PubMed
2,868,744Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2868744PubMed
2,860,940Pharmacological activity of ACC-7513, a selective alpha-adrenoceptor and 5-hydroxytryptamine receptor blocking agent.Br J Pharmacol1985https://conductscience.org/library/papers/2860940PubMed
2,859,047Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.Br J Clin Pharmacol1985https://conductscience.org/library/papers/2859047PubMed
1,980,074Differential regulation of human cardiac beta-adrenergic and muscarinic receptors by chronic beta-adrenoceptor antagonist treatment.Br J Clin Pharmacol1990https://conductscience.org/library/papers/1980074PubMed
1,979,509Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium.Br J Pharmacol1990https://conductscience.org/library/papers/1979509PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37065

GET https://conductscience.org/api/papers/v1/37065/references?page=2